News
ZYBT
0.6980
-7.55%
-0.0570
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 6d ago
Weekly Report: what happened at ZYBT last week (0706-0710)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 07/09 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 07/06 21:05
Weekly Report: what happened at ZYBT last week (0629-0703)?
Weekly Report · 07/06 09:11
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 06/29 21:05
Weekly Report: what happened at ZYBT last week (0622-0626)?
Weekly Report · 06/29 09:11
Zhengye Biotechnology says director Jiang Ping files initial beneficial ownership statement
PUBT · 06/25 15:39
Weekly Report: what happened at ZYBT last week (0615-0619)?
Weekly Report · 06/22 09:12
Weekly Report: what happened at ZYBT last week (0608-0612)?
Weekly Report · 06/15 09:12
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 06/12 21:05
Weekly Report: what happened at ZYBT last week (0601-0605)?
Weekly Report · 06/08 09:11
Zhengye Biotechnology receives deficiency notice over minimum bid price
TipRanks · 06/04 20:40
Zhengye Biotechnology Faces Nasdaq Minimum Bid Price Deficiency After May 29 Notice
TipRanks · 06/04 20:28
Zhengye Biotechnology Receives Nasdaq Listing Notice Of Failure To Maintain Minimum Bid Pricing Requirements
Benzinga · 06/04 20:11
Zhengye Biotechnology receives Nasdaq notice for US$ 1 minimum bid price deficiency
PUBT · 06/04 20:08
Zhengye Biotechnology gets Nasdaq notice for US$ 1 minimum bid price deficiency
PUBT · 06/04 20:07
ZHENGYE BIOTECHNOLOGY HOLDING LIMITED RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM BID PRICE DEFICIENCY
Reuters · 06/04 20:05
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Barchart · 06/04 15:05
Weekly Report: what happened at ZYBT last week (0525-0529)?
Weekly Report · 06/01 09:12
More
Webull provides a variety of real-time ZYBT stock news. You can receive the latest news about Zhengye Biotechnology Holding Limited through multiple platforms. This information may help you make smarter investment decisions.
About ZYBT
Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.